[Retroperitoneal lymphadenectomy in non-seminomatous stage I, IIa and IIb testicular tumors].
Between 1961 and 1985, 190 retroperitoneal lymph node dissections (RLND) have been performed in the Urological Clinic of the University Hospital of Zurich in patients with low stage (I, IIa, IIb) non seminomatous germ-cell testicular cancer. Indication, operative technic, complications (8,9%, dry ejaculation in 27%) and the results of the operation are pointed out (relapse rate in stage I: 10%, IIa: 35%, IIb: 59% without and 14% with adjuvant chemotherapy). The question is analysed if this primary surgical approach in this primary surgical approach in these stages, simultaneously a diagnostic and therapeutic procedure, is still indicated in the era of efficacious chemotherapy.
Jaeger
P
P
Urologische Klinike, Universitätsspital, Zürich.
Hauri
D
D
D004542:Ejaculation; D007172:Erectile Dysfunction / Q000209:etiology / Q000503:physiopathology; D005069:Evaluation Studies as Topic; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D009373:Neoplasms, Germ Cell and Embryonal / Q000473:pathology / Q000601:surgery*; D011183:Postoperative Complications / Q000209:etiology; D012187:Retroperitoneal Space; D013736:Testicular Neoplasms / Q000473:pathology / Q000601:surgery*
Die retroperitoneale Lymphadenektomie beim nichtseminomatösen Hodentumor in den Stadien I, IIa und IIb.